Recombinant Human VNN3 Protein，His

VNN3 (vanin-3) is a member of the family of pantetheinases, enzymes that play a crucial role in the metabolism of coenzyme A and the regulation of cellular redox state. Research into VNN3 has gained momentum due to its involvement in various physiological processes and pathophysiological conditions, including inflammation, oxidative stress, and cancer. It is primarily expressed in tissues such as the brain, heart, and immune cells, indicating its importance in both neurological functions and immune response. Recent studies have suggested that VNN3 may act as a modulator of inflammation, possibly influencing the development of chronic diseases. Furthermore, the exploration of VNN3 as a therapeutic target has been fueled by the observation that modulating its activity can alter disease outcomes in models of autoimmune disorders and tumorigenesis. The recombinant expression of VNN3 protein facilitates a better understanding of its structure-function relationships, allowing researchers to investigate potential inhibitors or activators that could serve as novel therapeutic agents. As such, the study of VNN3 not only contributes to the fundamental understanding of enzymatic roles in cellular function but also opens new avenues for therapeutic intervention in diseases where inflammation and oxidative stress play pivotal roles. Overall, VNN3 represents a promising candidate for future research aimed at elucidating its biological functions and therapeutic potential in various clinical applications.